Fig. 4From: Efficacy of concurrent treatments in idiopathic pulmonary fibrosis patients with a rapid progression of respiratory failure: an analysis of a national administrative database in JapanKaplan-Meier survival estimates according to the different doses of co-trimoxazole. A log-rank test revealed significant differences between all of the groups. High-dose (solid line, 74 patients), low-dose (broken line, 41 patients), none (dotted line, 94 patients)Back to article page